Daniel Ambort
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Gastroenterology top 5%
- Gastrointestinal motility and disorders
Papers in
-
- Protease and Inhibitor Mechanisms 3
-
- Glycosylation and Glycoproteins Research 5
- Co-authors
- Gunnar C. Hansson (6 shared papers)Malin Johansson (5 shared papers)Anna Ermund (3 shared papers)Jenny K. Gustafsson (3 shared papers)Harriet E. Nilsson (3 shared papers)Hans Hebert (3 shared papers)Henrik Sjövall (2 shared papers)Malin Bäckström (3 shared papers)
- Journals
- PLoS ONE (2 papers)Journal of Molecular Biology (1 paper)FEBS Journal (1 paper)Matrix Biology (1 paper)The Journal of Experimental Medicine (1 paper)
- Partner nations
- SwedenSwitzerlandGermany
In The Last Decade
Daniel Ambort
11 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 89
- Pharmaceutical Science 96
- Gastroenterology 79
- Molecular Biology 546
- Pulmonary and Respiratory Medicine 224
- Endocrinology 28
Countries citing papers authored by Daniel Ambort
This map shows the geographic impact of Daniel Ambort's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Ambort with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Ambort more than expected).
Fields of papers citing papers by Daniel Ambort
This network shows the impact of papers produced by Daniel Ambort. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Ambort. The network helps show where Daniel Ambort may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Ambort, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 435 | |
| 2 | 2012 | 290 | |
| 3 | 2012 | 287 | |
| 4 | 2011 | 82 | |
| 5 | 2008 | 63 | |
| 6 | 2013 | 47 | |
| 7 | 2014 | 42 | |
| 8 | 2008 | 28 | |
| 9 | 2009 | 24 | |
| 10 | 2008 | 12 | |
| 11 | 2008 | 3 |
About Daniel Ambort
Daniel Ambort is a scholar working on Cancer Research, Molecular Biology, Gastroenterology, Nephrology and Spectroscopy, having authored 11 papers that have together received 1.3k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (5 papers), Protease and Inhibitor Mechanisms (3 papers), Cystic Fibrosis Research Advances (1 paper), Advanced Proteomics Techniques and Applications (1 paper), Digestive system and related health (1 paper), Renal Diseases and Glomerulopathies (1 paper) and Gastrointestinal motility and disorders (1 paper). The work is most often cited by research in Pharmaceutical Science (96 citations), Gastroenterology (79 citations), Molecular Biology (546 citations), Pulmonary and Respiratory Medicine (224 citations) and Endocrinology (28 citations). Daniel Ambort has collaborated with scholars based in Sweden, Switzerland and Germany. Frequent co-authors include Gunnar C. Hansson, Malin Johansson, Anna Ermund, Jenny K. Gustafsson, Harriet E. Nilsson, Hans Hebert, Henrik Sjövall, Malin Bäckström, Sjoerd van der Post and Philip J.B. Koeck. Their work appears in journals such as PLoS ONE, Journal of Molecular Biology, FEBS Journal, Matrix Biology and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.